Patent Assignment
Reel/Frame 011901/0711
Assignment of Assignor's Interest
Recorded: 2001-06-15
Pages: 3
Assignors
RAMSTEDT, URBAN
Executed: 2001-04-26
EBERHARDT, BRIDGET
Executed: 2001-05-12
PORTER-BROOKS, JULIE
Executed: 2001-05-19
Assignee
AVANT IMMUNOTHERAPEUTICS, INC.
119 FOURTH AVENUE, NEEDHAM, MASSACHUSETTS, 02494
Covered Property
(1)
Method of Using Sfv HUTAT2 in Intracellular Targeting Generation of Ln-Hsfvtat Packaging Cell Lines
Patent:
6,479,284 →
Application:
09/660,169 →
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 14, 2000
From: MARASCO, WAYNE A.; LAVECCHIO, JOYCE; MHASHILKAR, ABNER M.
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 011340/0597 →
Assignment of Assignor's Interest
Dec 14, 2000
From: DAVID, RING
To: CHIRON CORPORATION
Reel/Frame 011340/0618 →
Confirmatory License
Jul 14, 2008
From: DANA-FARBER CANCER INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021232/0787 →
Change of Name
Mar 9, 2009
From: AVANT IMMUNOTHERAPEUTICS, INC. (NEEDHAM, MASSACHUSETTS)
To: CELLDEX THERAPEUTICS, INC.
Reel/Frame 022380/0239 →
Confirmatory License
Sep 27, 2016
From: DANA-FARBER CANCER INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR
Reel/Frame 039868/0084 →